Journal of Clinical Endocrinology & Metabolism, Vol 81, 49-58, Copyright © 1996 by Endocrine Society

ARTICLES

Angiotensin II receptor characteristics and subtype expression in uterine arteries and myometrium during pregnancy

BE Cox, RA Word and CR Rosenfeld
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235, USA.

The uteroplacental vasculature is less sensitive to angiotensin II (ANG II)-induced vasoconstriction than the systemic vasculature. Although the mechanism(s) responsible is unclear, uterine arteries (Ua) may demonstrate ANG II receptor (AT receptors) down-regulation or expression of AT2 receptors, which do not mediate vasoconstriction. We determined AT receptor binding characteristics and subtype expression in Ua from normotensive pregnant (n = 14; 38 +/- 0.5 weeks gestation) and nonpregnant (n = 28) women. Comparative studies were performed with myometrium, a nonvascular smooth muscle. We measured binding density (Bmax) and affinity (Kd) in plasma membrane preparations employing radioligand binding. Receptor subtypes were assessed by inhibiting [125I]ANG II binding with specific antagonists. During pregnancy, the Ua Bmax and Kd were unchanged (P > 0.1; 221 +/- 36 vs. 159 +/- 27 fmol/mg protein and 0.8 +/- 0.1 vs. 0.9 +/- 0.1 nmol/L, respectively). However, myometrial Bmax decreased 92% (580 +/- 129 vs. 44 +/- 7 fmol/mg protein; P < 0.001), and Kd rose 4-fold (1.5 +/- 0.4 to 6.0 +/- 0.6 nmol/L; P < 0.001). AT1/AT2 expression averaged 15%/85% in Ua from nonpregnant and pregnant women, whereas in myometrium, values were 10%/90% and 60%/40%, respectively. In myometrium from laboring women (n = 8), force (1.38 +/- 0.14 to 1.59 +/- 0.12 x 10(4) N/m2; P < 0.04) and contractile frequency (0.038 +/- 0.05 to 0.116 +/- 0.014 contractions/min; P < 0.001) increased with 10(-5) mol/L ANG II and were abolished by AT1 receptor inhibition. Myometrium from nonpregnant women (n = 3) was unresponsive, and AT2 inhibition did not alter responses. In nonpregnant women, AT2 receptors predominate in Ua and myometrium. Although Ua AT receptors are unaltered during pregnancy, myometrial Bmax decreases, reflecting decreases in the expression of AT2 >> AT1 receptors and differential receptor regulation.

This article has been cited by other articles:

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				J. St-Louis, B. Sicotte, A. Beausejour, and M. Brochu Remodeling and angiotensin II responses of the uterine arcuate arteries of pregnant rats are altered by low- and high-sodium intake Reproduction, February 1, 2006; 131(2): 331 - 339. [Abstract] [Full Text] [PDF]

				M. Tsuda, M. Iwai, J.-M. Li, H.-S. Li, L.-J. Min, A. Ide, M. Okumura, J. Suzuki, M. Mogi, H. Suzuki, et al. Inhibitory Effects of AT1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress Hypertension, April 1, 2005; 45(4): 545 - 551. [Abstract] [Full Text] [PDF]

				B. I. Levy Can Angiotensin II Type 2 Receptors Have Deleterious Effects in Cardiovascular Disease?: Implications for Therapeutic Blockade of the Renin-Angiotensin System Circulation, January 6, 2004; 109(1): 8 - 13. [Full Text] [PDF]

				D. Henrion, N. Kubis, and B. I. Levy Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation Hypertension, November 1, 2001; 38(5): 1150 - 1157. [Abstract] [Full Text] [PDF]

				S. AbdAlla, H. Lother, A. M. Abdel-tawab, and U. Quitterer The Angiotensin II AT2 Receptor Is an AT1 Receptor Antagonist J. Biol. Chem., October 19, 2001; 276(43): 39721 - 39726. [Abstract] [Full Text] [PDF]

				C. R. Rosenfeld Mechanisms regulating angiotensin II responsiveness by the uteroplacental circulation Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1025 - R1040. [Abstract] [Full Text] [PDF]

				B. E. Cox, C. E. Williams, and C. R. Rosenfeld Angiotensin II indirectly vasoconstricts the ovine uterine circulation Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R337 - R344. [Abstract] [Full Text] [PDF]

				D. S. Lambers, S. G. Greenberg, and K. E. Clark Functional role of angiotensin II type 1 and 2 receptors in regulation of uterine blood flow in nonpregnant sheep Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H353 - H359. [Abstract] [Full Text] [PDF]

				V. P. Fomin, B. E. Cox, and R. A. Word Effect of progesterone on intracellular Ca2+ homeostasis in human myometrial smooth muscle cells Am J Physiol Cell Physiol, February 1, 1999; 276(2): C379 - C385. [Abstract] [Full Text] [PDF]

				R. M. Touyz, G. He, L.-Y. Deng, and E. L. Schiffrin Role of Extracellular Signal-Regulated Kinases in Angiotensin II–Stimulated Contraction of Smooth Muscle Cells From Human Resistance Arteries Circulation, January 26, 1999; 99(3): 392 - 399. [Abstract] [Full Text] [PDF]

				J. R. Kaiser, B. E. Cox, T. A. Roy, and C. R. Rosenfeld Differential development of umbilical and systemic arteries. I. ANG II receptor subtype expression Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R797 - R807. [Abstract] [Full Text] [PDF]

				F. Broughton Pipkin and P. N. Baker Angiotensin II Has Depressor Effects in Pregnant and Nonpregnant Women Hypertension, November 1, 1997; 30(5): 1247 - 1252. [Abstract] [Full Text]

				I. M. Bird, J. Zheng, J. M. Cale, and R. R. Magness Pregnancy Induces an Increase in Angiotensin II Type-1 Receptor Expression in Uterine But Not Systemic Artery Endothelium Endocrinology, January 1, 1997; 138(1): 490 - 498. [Abstract] [Full Text] [PDF]